Cross-cultural Adaptation and Validity of the Arabic-translated NEUROPATHY-SPECIFIC QUALITY of LIFE Questionnaire

Launched by CAIRO UNIVERSITY · Jul 1, 2024

Keywords

ClinConnect Summary

This clinical trial is focused on creating and validating an Arabic version of a questionnaire designed to assess the quality of life in diabetic patients suffering from diabetic neuropathies, which is nerve damage caused by diabetes. By translating and culturally adapting the Neuro Qol questionnaire, researchers aim to make it suitable for Arabic-speaking patients, allowing for better understanding and treatment of their condition.

To be eligible for this study, participants need to be Arabic speakers aged between 18 and 70 who have been diagnosed with diabetes. They should not have any other major neurological issues or recent physical trauma that could affect their nerve health. Those who join the trial will help researchers ensure that the Arabic version of the questionnaire is accurate and reliable, contributing valuable information to improve care for diabetic patients in Arabic-speaking countries. Participants can expect to complete the questionnaire and may also be involved in discussions about their experiences with diabetic neuropathy.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Arabic is their first language The absence of any other neurological diagnosis affecting the sensory and motor system, such as stroke or multiple sclerosis
• • Age ranges between 18 and 70 years,
• • History of DM diagnosed by a physician and confirmed by either hemoglobin A1c ≥6.5% or the use of hypoglycemic agents.
• Exclusion Criteria:
• • A hospital inpatient
• • Had pre-existing comorbidities such as cancer, shingles or other neuropathic pain entity that predated diabetes or can mimic or cause a neuropathic pain that is not arising as a result of diabetes.
• • Pregnant patients as diabetes may be of gestational type
• • Had recently experienced physical trauma that may have contributed to neuropathic pain had trauma or dermatological diseases of the skin as this could affect skin sensitivity (e.g. wounds, psoriasis and eczema).